1PLANCHON S M,WAITE K A,ENG C.The nuclear affairs of PTEN[J].J Cell Sci,2008,121(Pt3):249-253.
2STILES B,WANG Y,STAHL A,et al.Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity[corrected].Proc Natl Acad Sci U S A,2004,101(7):2082-2087.
3STILES B L.Phosphatase and tensin homologue deleted on chromosome 10:Extending its PTEN tacles[J].Int J Biochem Cell Biol,2009,41(4):757-761.
4WENG L P,GIMM O,KUM J B,et al.Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependentcell death[J].Hum Mol Genet,2001,10(3):251-258.
5WAITE K A,ENG C.Protean PTEN:form and function[J].Am J Hum Genet,2002,70(4):829-844.
6HAMADA K,SASAKI T,KONI P A,et al.The PTEN/PI3K pathway Governs normal vascular development and tumor angiogenesis[J].Genes Dev,2005,19(17):2054-2065.
7MEUILLET E J,MAHADEVAN D,BERGGEREN M,et al.Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase ativity and membrane binding:a mechanism for the functional loss of PTEN's tumor suppressor activity[J].Arch Biochem Biophys,2004,429(2):123-133.
8GOBERDHAN D C,WILSON C.PTEN:tumour suppressor,multifunctional growth regulator and more[J].Hum Mol Genet,2003,12(2):239-248.
9FURUKAWA K,KUMON Y,HARADA H,et al.PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules[J].Int J Oncol,2006,29 (1):73.
10ABE T,TERADA K,WAKIMOTO H,et al.PTEN decrease in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli[J].Cancer Res,2003,63 (9):2300.
8Lee J I, Soria J C, Hassan K A, et al. Loss of PTEN expression as a prognostic marker for tongue cancer[J]. Arch Otolaryngol Head Neck Surg,2001,127(12) : 1441-1445.
9Teng Y, Sun A N, Pan X C, et al. Synergistic function of smad4 and PTEN in suppressing forestomaeh squamous cell carcinoma in the mouse[J]. Cancer Research,2006,66(14):6972-6981.
10Li D M, Sun H. TEP1, encoded by a candidate tumor suppres sor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta[J]. Cancer Res,1997,57(11): 2130-2136.
2Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997,275(5308): 1943-1947.
3Taheri ZM, Mehrafza M, Mohammadi F, et al. The diagnostic value of K-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations[J].Arch Pathol Lab Med, 2008,132(4) .. 694-697.
4Kawaski H, Altieri DC, Lu CD,et al. Inhibition of apoptosis by surviving predicts shorter survival rates in colorectal cancer[J]. Cancer Res, 1998,58(22)..5071-5074.
5Colakoglu T, Yildirim S, Kayaselcuk F, et al. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?[J].Am I Surg,2008,195(6):T19-725.
6Fusco A, Zatelli MC, Bianchi A, et M. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting piturtary adenomas[J]. J Clin Endocrinol Metab, 2008, 93(7) :2746- 2750.
